Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nvidia | 4.73% | $37.72M | $4.58T | 52.40% | 76 Outperform | |
| Apple | 4.42% | $35.26M | $3.80T | 7.14% | 79 Outperform | |
| Lam Research | 2.97% | $23.72M | $299.51B | 218.80% | 77 Outperform | |
| AbbVie | 2.87% | $22.85M | $395.77B | 27.77% | 66 Neutral | |
| Amgen | 2.80% | $22.33M | $189.18B | 21.49% | 77 Outperform | |
| Mastercard | 2.75% | $21.92M | $467.33B | -5.17% | 75 Outperform | |
| Bristol-Myers Squibb | 2.68% | $21.37M | $113.11B | -5.91% | 78 Outperform | |
| Tapestry | 2.52% | $20.10M | $26.10B | 69.38% | 69 Neutral | |
| Gilead Sciences | 2.49% | $19.88M | $174.90B | 47.47% | 78 Outperform | |
| Colgate-Palmolive | 2.48% | $19.78M | $69.13B | -4.25% | 63 Neutral |